Buffer-Loaded pH-Regulating Hydrogels for Tumor Acidosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing cancer treatments face challenges with chemoresistance due to ion trapping, where extracellular acids prevent weak base chemotherapeutics from permeating through cell membranes, and systemic pH buffering solutions are impractical and ineffective for long-term pH regulation in cancer microenvironments.
Innovation Solution
Hydrogel delivery vehicles, such as gellan and PEGDA hydrogels, encapsulating pH buffers like bicarbonate, provide targeted and sustained pH regulation, preventing ion trapping by neutralizing the extracellular environment and enhancing chemotherapeutic efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic pH buffering solutions are used, then pH neutralization is achieved, but bioavailability is poor and side effects occur
Solution Approach 1:
The patent applies local quality by transitioning from systemic pH buffering to localized tumor-targeted buffering. The hydrogel delivery system releases bicarbonate buffers specifically at the tumor site, creating a localized neutral pH environment without affecting systemic pH levels. This resolves the contradiction by achieving reliable pH neutralization where needed while avoiding the harmful side effects of systemic buffer therapy.
Solution Approach 2:
The patent uses hydrogel as an intermediary carrier to deliver bicarbonate buffers to the tumor microenvironment. The hydrogel acts as a mediator between the buffer and the tumor cells, enabling controlled release and localized action. This intermediary approach allows effective pH neutralization at the tumor site while preventing the harmful effects associated with direct systemic buffer administration.
2Duration of action of moving object
If liposomal or cellulose bicarbonate delivery vehicles are used, then short-term pH neutralization is achieved, but active buffering capacity is lacking and long-term regulation cannot be maintained
Solution Approach 1:
The patent employs composite materials by combining hydrogel matrix with bicarbonate buffer systems. The hydrogel provides structural support and controlled release capability, while the bicarbonate provides active buffering capacity. This composite approach enables both long-term sustained release (resolving the duration issue) and maintains reliable active buffering capacity (resolving the reliability issue), overcoming the limitations of simple liposomal or cellulose carriers.
Solution Approach 2:
The patent achieves continuity of useful action through the hydrogel's sustained release mechanism. The hydrogel matrix continuously releases bicarbonate buffers over extended periods, maintaining active buffering capacity throughout the release duration. This continuous action resolves the contradiction by providing both long-term duration and reliable buffering capacity, unlike single-burst release systems that lose effectiveness over time.
3Productivity
If weak base chemotherapeutics are used in acidic environment, then chemotherapy is administered, but ion trapping occurs and cellular uptake is reduced
Solution Approach 1:
The patent applies preliminary action by first neutralizing the acidic tumor microenvironment with bicarbonate buffers released from the hydrogel, before or during chemotherapeutic administration. This preliminary pH neutralization prevents ion trapping of weak base chemotherapeutics, allowing them to maintain their unprotonated form and effectively permeate cell membranes. This resolves the contradiction by eliminating the harmful ion trapping effect while preserving or enhancing chemotherapeutic productivity.
Solution Approach 2:
The patent converts the harmful acidic environment into a benefit by using the acidity itself as a trigger for bicarbonate release. The acidic tumor microenvironment promotes protonation of the buffer, driving bicarbonate release precisely where needed. This converted approach eliminates ion trapping and enhances chemotherapeutic efficacy while utilizing the原有的 acidic condition, transforming the harmful factor into a beneficial trigger mechanism.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The hydrogel systems effectively regulate pH over extended periods, reducing ion trapping and increasing the efficacy of weak base chemotherapeutics like doxorubicin, thereby inhibiting cancer cell proliferation and metastasis.
Implementation Method 1
Hydrogels loaded with drug or pH buffer solutions swell and release encapsulants down concentration gradients between the hydrogel and its environment
Implementation Method 2
Hydrogels are polymeric materials characterized by their cross-linked mesh network, hydrophilic nature, high water retention capability
Implementation Method 3
Ionization of the extracellular space renders weak base chemotherapeutics, e.g., doxorubicin, incapable of permeating through phospholipid cell membranes. This form of chemoresistance is termed 'ion trapping'. Ion trapping's effects diminish by the neutralization of the tumor microenvironment using bicarbonate buffer delivery
Data Source
AI summary
The invention provides pH regulation systems of buffer-loaded hydrogels that can regulate pH of solutions for long periods of time. These pH-regulating hydrogels may be used in a variety of pH-dependent systems, including water treatment, agricultural soil, and biological applications. Demonstrated is an application in increasing the efficacy of weak base chemotherapeutics used for cancer treatments.